David E. Selk - Concepedia

Author

David E. Selk

Also Known As

D E Selk, D. E. SELK, D. SELK, David E. Selk, David Selk

Publications

422

Citations

H-Index

Concepts

All Affiliations

David E. Selk is an author at CNS Research (United States) specializing in medicine, drug discovery, and medicinal chemistry.

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	136
2	Natural Sciences	2	2	52
3	Biochemistry	2	2	52
4	Social Sciences	1	1	84
5	Chemical Biology	1	1	21

David E. Selk

Publications

418

Citations

H-Index

Page 1

	Year	Citations
Pharmacological evaluation of novel Alzheimer's disease therapeutics: acetylcholinesterase inhibitors related to galanthamine. Gina M. Bores, Francis P. Huger, Wayne W. Petko, Journal of Pharmacology and Experimental Therapeutics	1996	247
On the effect of neonatal nitric oxide synthase inhibition in rats: a potential neurodevelopmental model of schizophrenia Mark D. Black, David E. Selk, Janice M. Hitchcock, Neuropharmacology PsychiatryPsychotic DisorderSynthase InhibitionPsychopharmacologySchizophrenia	1999	84
Pharmacological Activity and Safety Profile of P10358, a Novel, Orally Active Acetylcholinesterase Inhibitor for Alzheimer’s Disease Craig P. Smith, Gina M. Bores, Wayne W. Petko, Journal of Pharmacology and Experimental Therapeutics	1997	35
Synthesis and Evaluation of 5-Amino-5,6,7,8-tetrahydroquinolinones as Potential Agents for the Treatment of Alzheimer's Disease David M. Fink, Gina M. Bores, Richard C. Effland, Journal of Medicinal Chemistry Combinatorial ChemistryMedicinal ChemistryBioorganic ChemistryBiochemistryPotential Agents	1995	31
Synthesis and preliminary structure-activity relationships of 1-[(3-fluoro-4-pyridinyl)amino]-3-methyl-1H-indol-5-yl methyl carbamate (P10358), a novel acetylcholinesterase inhibitor Lawrence L. Martin, Larry J. Davis, Joseph Klein, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryBiochemistryNatural SciencesMedicinePreliminary Structure-activity Relationships	1997	21

Page 1